For Immediate Release
R. Kelly Schwalbe
(816)474-3166
News Archive
- 08.12.10 - Pre-Breeding Vaccinations Set the Stage for Improved Health
- 07.27.10 - Duramune Lyme Vaccine Approved for Use in Dogs
- 06.13.10 - Bovine Respiratory Disease Takes an Economic Toll on the Herd
- 06.07.10 - Management and Vaccination Keep Trichomoniasis at Bay
- 06.01.10 - Adding to the Bottom Line with Increased Cow Comfort
- 05.10.10 - Moreaux Presented BIVI Equine Leadership Award
- 05.05.10 - Test Herd, Then Treat to Avoid Parasite Resistance
- 04.05.10 - Strong Deworming Program Pays for Itself
- 11.23.09 - New Vetera West Nile Virus Vaccines
- 11.12.09 - PROZINC™ (protamine zinc recombinant human insulin) Receives FDA Approval
- 10.26.09 - Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business from Pfizer
- 10.01.09 - Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations
- 09.21.09 - BIVI Aquires Many of Fort Dodge's Products
- 08.17.09 - Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations
- 08.09.09 - Boehringer Ingelheim Announces 2009 PRRS Research Award Recipients
- 08.05.09 - Swine Industry Call for PRRS Research Proposals
- 08.01.09 - BIVI Partners with EQUUS Foundation
- 05.28.09 - Swine Vets Complete Veterinary Program
- 04.27.09 - Joint Health Management Program Launched
- 03.16.09 - Mondaca Joins Swine Team
- 02.05.09 - BIVI Hires Brand Managers
- 08.11.08 - CircoFLEX-MycoFLEX Receives Approval
- 02.11.08 - Express Whole Herd Approved
- 05.02.07 - Baysinger Joins BIVI Swine Team
- 05.02.07 - Circovirus Receives Approval
- 04.08.07 - Express® FP 3 VL5 Announcement
- 04.08.07 - BIVI Recieves BVD PI Prevention Claim
News & Announcements
Moreaux Presented BIVI Equine Leadership Award
ST. JOSEPH, MO. (May 10, 2010) – Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces that Shannon John J. Moreaux, DVM, assistant professor of equine science at Montana State University, has been awarded the BIVI Equine Leadership Award.
The award is given to those in the equine industry who have demonstrated outstanding leadership by promoting the benefits of horse ownership, advancing modern equine wellness programs and increasing the overall awareness of the industry.
“Dr. Moreaux has been instrumental in the growth of Montana State University’s equine science program since its inception in 2002,” says Dr. Rob Keene, Montana-based equine professional services veterinarian for BIVI. “The Montana State program started with 11 students, and now has 65. That substantial growth is in large part due to the dedication of Dr. Moreaux and his passion for the horse industry.”
Dr. Moreaux has increased the stature of the equine industry in Montana by encouraging those interested in veterinary medicine to consider a career in equine medicine and to stay and work in the state after graduation.
“Our goal since the beginning has been to produce graduates that are well-qualified to get a job in the equine industry," says Moreaux. “But if we can keep them here in our state, that’s even better.”
BIVI, a leader in equine joint health management products, believes that when it comes to the health and wellness of all horses, the veterinarian is the expert.
“BIVI and the entire industry recognize and support Dr. Moreaux’s efforts to expand the number of graduates from the equine science program at Montana State University,” says Jane Smith, executive director, equine division, BIVI. “We believe that owners and their horses are best served by well-qualified and trained equine health professionals who have a passion for this industry, and Dr. Moreaux’s work exemplifies these characteristics.”
For more information about the BIVI Equine Leadership Award and products offered by BIVI visit
www.bi-vetmedica.com.
About Boehringer Ingelheim
About Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.
About Boehringer Ingelheim Vetmedica, Inc.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, MO), is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.
Visit www.bi-vetmedica.com for more information.